Abstract

γ-Secretase is a multisubunit membrane protein complex consisting of presenilin (PS1), nicastrin (NCT), anterior pharynx-1, and presenilin enhancer 2. To analyze the activity of familial Alzheimer disease mutants and to understand the roles of the subunits, we established a yeast transcriptional activator Gal4p system with artificial γ-secretase substrates containing amyloid precursor protein or Notch fragments. The γ-secretase activities were evaluated by transcriptional activation of reporter genes upon Gal4p release from the membrane-bound substrates, i.e. growth of yeast on histidine and adenine, or β-galactosidase assay. We screened and evaluated γ-secretase mutants using this reconstitution system in yeast, which does not possess endogenous γ-secretase activity. When we introduced familial Alzheimer mutants of PS1 in this system, their activities were shown to be loss of function. Although the protease activity of wild type PS1 depends on the other three subunits introduced, we obtained 15 new PS1 mutants, which are active in the absence of NCT. They possessed a S438P mutation at the ninth transmembrane domain (TM9) together with one missense mutation distributed through transmembrane and loop regions. These mutations were not related to familial Alzheimer mutations of PS1 as identified so far. The S438P mutant was partially active but required other mutations for full activation. Results of the β-galactosidase assay suggested that they have wild type protease activities, which were further confirmed by the endoproteolysis of PS1, amyloid β peptides, and Notch intracellular domain production in mammalian cells. These results suggest that NCT is dispensable for the protease activity of γ-secretase.

Highlights

  • The interactions between the subunits and the arrangement of PS1 transmembrane domains were partly understood from biochemical analyses

  • Prior to the entry into the catalytic site, the substrate interacts with the recognition site, which may be identical to the binding sites of APP and telencephalin (TM1 and the carboxyl-terminal region containing TM9) [17]

  • We introduced familial Alzheimer disease (FAD) mutations in the PS1 gene and transformed them into yeast together with three other subunits

Read more

Summary

EXPERIMENTAL PROCEDURES

␥-Secretase and APP Constructs—The expression constructs for ␥-secretase were prepared as described [2] with minor modifications. APP-based substrate, C1–55Gal4p, and Notch-based substrate, NotchTM-Gal4p, were prepared; DNA fragment for C1–55 (amino acids 672–726 of the human APP770 isoform) or NotchTM (amino acids 1703–1754 of the mouse Notch-1) was amplified by PCR using primers encoding a 19-amino acid signal peptide sequence from yeast invertase (SUC2) to make SUC2-C1–55 or SUC2-NotchTM. They were ligated with the GAL4 gene and cloned into BamHI and EcoRI sites of p426ADH [33].

RESULTS
Other subunit No of cells tested Positive clones False positives
No of positive clones
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call